Texas Governor Abbott expands the ban on state use of certain technologies to protect against espionage and data theft, particularly from China-related entities, in collaboration with the TXCC.

AG Letitia James leads a bipartisan group urging xAI to strengthen controls on Grok to prevent creation and sharing of sexualized nonconsensual images.

Governor Kathy Hochul announces a $3 million renovation for SUNY Upstate Medical Center's CNY Biotech Accelerator to expand life science incubator space in Syracuse.

Gabby Voit at UWM studies zebrafish embryonic development to gain insights into human brain development and genetic mutations related to fertility issues. Her research could help understand developmental disabilities and genetic conditions.

Bora Biologics opened a $30M expansion in Sorrento Valley, adding 2,000L bioreactors and upgraded GMP processing to boost local biologics capacity.

Northwestern and Lurie Children’s unveiled a hair‑thin probe that measures fetal heart rate, oxygen and temperature during in‑utero surgery.

Hillsborough County Solid Waste released an interactive virtual tour of its Waste-to-Energy Facility that burns up to 1,800 tons of trash daily, powering 35,000 homes and recycling metals.

A UW study of 404 people found prior traumatic stress was linked to worse autonomic and multisystem symptoms after COVID‑19, suggesting new paths for treatment.

UCLA researchers developed an AI that flags likely undiagnosed early Alzheimer’s in medical records, showing roughly 80% sensitivity and built‑in fairness measures. The team plans broader testing before clinical use.

The University of Cincinnati is hosting an AI & Emerging Technology Symposium on Feb. 18 for the UC community, focusing on the future of education and more.

A UT Southwestern survey of 924 Dallas patients found broad support for AI‑assisted mammogram reads — but most women insisted a radiologist must sign off and be asked for consent.

Intel's stock fell 12% due to struggles with high demand for AI data-center chips, despite efforts to meet market demands, leading to a Q4 net loss of $333 million and revenue drop to $13.7 billion.

NIH announced it will no longer fund research using fetal tissue from elective abortions, citing alternatives; scientists warn it could slow vital studies on disease and development.